Published 8 days ago • loading... • Updated 8 days ago

This Biotech, Up 188% Since April, Just Crashed 55%. Here's Why.

Shares of Arcturus Therapeutics crashed more than 50% early Wednesday on mixed test results for its experimental cystic fibrosis treatment.

Shares of Arcturus Therapeutics crashed more than 50% early Wednesday on mixed test results for its experimental cystic fibrosis treatment.

8 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated8 days agoBias Distribution

100% Right

100% Right

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Investor's Business Daily broke the news in 8 days ago on Wednesday, October 22, 2025.

Sources are mostly out of (0)